Focus
Tirzepatide
LATEST
FDA Investigating Reports of Alopecia and Suicidal Ideation as Possible Weight-Loss Drug Side Effects
The FDA is also investigating reported side effects of aspiration.
|
FDA Approved Nearly 50 Percent More Drugs in 2023 Than in 2022
Only 2018 featured a higher number of drug approvals.
|
Stopping Treatment With Popular New Weight-Loss Drug May Lead to Regained Weight
However, about 17 percent of individuals prescribed a placebo kept about 80 percent of their original weight loss, a new trial shows.
|
Safety Concerns Loom as Obesity Drugs Head to Clinical Trials in Kids as Young as 6
As childhood obesity rates surge globally, pharma giants test weight loss drugs on kids despite safety concerns over side effects and long-term health impacts.
|
FDA Urges Online Vendors to Stop Sale of Unapproved Weight Loss Drugs
The U.S. Food and Drug Administration has urged online vendors to stop selling unapproved semaglutide and tirzepatide drugs due to public health concerns.
|